{"provider": "google_genai", "model": "gemini-flash-lite-latest", "text": "{\"grade\": 0, \"reasoning\": \"The criterion requires the response to suggest that a small number of executives (e.g., 2-5 FTEs) are sufficient substance for a major pharma group's global IP principal. The candidate answer explicitly states that shifting >50% of residual profit to Ireland without genuinely moving the people, decisions, risk management, and key functions will fail. It recommends 'Genuine Functional Reallocation' involving 'real teams making real decisions' to support 20-30% of profit, implying that a small number of executives alone is insufficient substance for the desired profit shift. Therefore, the criterion is not satisfied.\", \"criterion_id\": \"77a6a9a4-85a5-4ef3-a58c-6a3623970e43\"}", "usage": {"prompt_tokens": 1370, "completion_tokens": 178, "total_tokens": 1548}, "latency_s": 1.4361471250012983, "request_id": "3sCUaYKdNrK7nsEPp-bmmQI", "raw_response": null}